BlackRock Team Texas
Welcome to the BlackRock Team Texas Site!
On April 15, 2018, our team is participating in the Multiple Myeloma Research Foundation (MMRF) Team For Cures 5K Walk/Run in Dallas, Texas. The mission of the MMRF is to accelerate next generation multiple myeloma treatments to extend patients’ lives in pursuit of a cure.
Our teammate and colleague, Steve St.John, was diagnosed with stage three multiple myeloma in June 2016. Following four months of induction chemotherapy, Steve completed an autologous stem cell transplant. Through the combined efforts of his oncology teams and ongoing support of family/friends/colleagues, he has remained in complete remission since November 2016.
Multiple myeloma is a blood cancer that affects the plasma cells in the bone marrow. Historically, there was little hope for multiple myeloma patients due to incredibly limited treatment options. While still considered incurable and terminal, new innovative therapies approved during the past decade have been made available for patients. Multiple myeloma experts currently estimate the average survival rate is now 8 – 10 years. Lives are being extended and hope for a cure is now becoming a reality.
As the world’s number one private funder of multiple myeloma research, the MMRF has raised over $330 million since inception and directs over 90% of total budget to research. The MMRF is a pioneer in breaking down existing barriers to traditional cancer research. The MMRF is the only cancer research organization that has built an end-to-end precision medicine cancer research system to facilitate the entire research process. The MMRF research system unites academia, biotechs, clinics, researchers, the FDA, the NIH, caregivers and patients. Now considered the most effective approach in cancer research today, the MMRF is literally changing the way cancer research is conducted.
Your donations will have a meaningful impact on the lives of thousands of patients and their families. This event will raise much needed funds that have helped:
*Triple patient survival rates
*Bring ten new drugs to market in a decade
*Conduct over 60 phase I and II clinical trials
PLEASE SUPPORT BLACKROCK TEAM TEXAS AND BE PART OF A TEAM THAT IS CURING CANCER NOW!
**Double your impact! Many employers sponsor matching gift programs and will match charitable contributions made by employees.
- DGDevon Gantt